Neuropeptides are major participants in the pathogenesis of colonic inflammation and Inflammatory Bowel Disease (IBD). We showed that the neuropeptide substance P (SP) plays a dual role in colitis, acting as a proinflammatory mediator in the acute phase of colitis, but promoting mucosal healing during the repair phase of inflammation. Recent novel results from our laboratory substantially advanced our understanding on the multiple roles SP-NK-1R interactions play in the pathophysiology of IBD-related colitis. We show that SP interaction with its neurokinin-1 receptor (NK-1R) mediates angiogenesis in vivo and in vitro by inducing secretion of the pro-angiogenic factor CCN1 and likely VEGF from colonocytes, which in turn stimulates neo- angiogenesis in human intestinal microvascular endothelial cells. This is the first paradigm of a neuropeptide involved in angiogenesis-IBD-related inflammation. We also found increased NK-1R expression and neoangiogenesis in the mesenteric fat depots during experimental colitis and identified expression of NK-1R in human mesenteric preadipocytes that respond to SP by increased activation of NF-B-related proinflammatory genes. These findings link for the first time SP-NK-1R-dependent changes in mesenteric fat depots with colitis and may be pathophysiologically relevant since abdominal fat wrapping and fat expansion are common findings in IBD patients. Our hypothesis is that SP via NK-1R stimulates expression of pro-angiogenic molecules on colonocytes and human mesenteric preadipocytes, which then promote angiogenesis related to the pathophysiology of colitis.
Aim 1 will study the role of SP in angiogenesis in the colonic mucosa during colitis using in vivo and in vitro angiogenesis-related systems. Studies in aim 2 will identify the signaling pathways in SP-mediated transcription of angiogenic factors in human colonocytes and mouse colon during colitis, focusing initially in CCN1 and VEGF. We also hypothesize that SP-mediated responses in human preadipocytes influence colitis in two ways, first by enhancing development and progress of colitis and second by stimulating proliferation of preadipocytes, leading to fat expansion and fat expansion-associated angiogenesis. Thus, aim 3 will study the effect of SP on mesenteric fat depot expansion during colitis, and investigate the role of angiogenesis in this response. Experiments investigating whether SP regulates fat expansion in human preadipocytes and changes the activity of related signaling molecules in these cells are also included in this aim. Our results might provide important insights on the importance of SP and NK-1R in angiogenesis during colitis and their role in inflammation of mesenteric fat depots observed in IBD and animal models of experimental colitis.

Public Health Relevance

This project will examine the mechanisms by which the neuropeptide substance P stimulates angiogenesis during intestinal inflammation in the colon and the mesenteric fat depots and how these responses participate in the pathogenesis of intestinal inflammation and Inflammatory Bowel Disease. Part of this project will also examine whether SP-mediated responses in human preadipocytes influence pathways that link colitis with the metabolic syndrome and insulin resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047343-19
Application #
8703074
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Hamilton, Frank A
Project Start
1994-09-15
Project End
2015-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
19
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Padua, David; Pothoulakis, Charalabos (2016) Novel approaches to treating Clostridium difficile-associated colitis. Expert Rev Gastroenterol Hepatol 10:193-204
Law, Ivy Ka Man; Jensen, Dane; Bunnett, Nigel W et al. (2016) Neurotensin-induced miR-133α expression regulates neurotensin receptor 1 recycling through its downstream target aftiphilin. Sci Rep 6:22195
Mashaghi, Alireza; Marmalidou, Anna; Tehrani, Mohsen et al. (2016) Neuropeptide substance P and the immune response. Cell Mol Life Sci 73:4249-4264
Vilisaar, Janek; Kawabe, Kiyokazu; Braitch, Manjit et al. (2015) Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis. J Neuroimmune Pharmacol 10:457-67
Fang, Kai; Sideri, Aristea; Law, Ivy Ka Man et al. (2015) Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells. Cell Mol Gastroenterol Hepatol 1:503-515
Sideri, Aristea; Stavrakis, Dimitris; Bowe, Collin et al. (2015) Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1. Am J Physiol Gastrointest Liver Physiol 308:G591-604
Sideri, Aristea; Bakirtzi, Kyriaki; Shih, David Q et al. (2015) Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients. Cell Mol Gastroenterol Hepatol 1:420-432
Jensen, Dane D; Halls, Michelle L; Murphy, Jane E et al. (2014) Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals. J Biol Chem 289:20283-94
Grasberger, Helmut; Chang, Lin; Shih, Wendy et al. (2013) Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol 108:1766-74
Tchkonia, Tamara; Thomou, Thomas; Zhu, Yi et al. (2013) Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab 17:644-56

Showing the most recent 10 out of 63 publications